جست‌وجوی استاد و پژوهشگر

• Biomaterials
• Tissue Engineering
• Mechanobiology
• +۳ مورد دیگر

Dr. Yogambha Ramaswamy is a Senior Lecturer in the School of Biomedical Engineering at The University of Sydney and a member of the Sydney Nano Institute. She holds a Master’s in Biotechnology from the University of Queensland and a PhD in Biomedical Engineering from the University of Sydney (2009). Her postdoctoral career began as a Vice-Chancellor’s Postdoctoral Research Fellow at the University of New South Wales, followed by a Peter Doherty Early Career Fellowship in 2013 before joining the University of Sydney in 2015. Dr. Ramaswamy’s research focuses on biomaterials, tissue engineering, and mechanobiology, with a particular emphasis on developing calcium silicate-based ceramics and biopolymers for orthopedic and regenerative applications. Her recent work explores the role of physical cues in modulating stem and cancer cell behavior. She teaches courses such as AMME1961 (Introduction to Biomedical Engineering B) and AMME5962 (Introduction to Mechanobiology). Her research has been supported by grants including the NHMRC Early Career Fellowship and collaborations with institutions like the CSIR-Indian Institute of Chemical Technology and the University of Otago. Her publications span biomaterials, nanotechnology, and mechanobiology, with recent work addressing atherosclerosis, hydrogel design, and nanomedicine. She currently supervises PhD students Frank (biomaterials) and Alexander (atherosclerosis research).

Vasilis Ntziachristosمشاهده پروفایل

استاد

• Biomedical Imaging
• Optoacoustic Imaging
• Medical Diagnostics
• +۳ مورد دیگر

Prof. Vasilis Ntziachristos is a Professor and Chair of Biological Imaging at the Technical University of Munich (TUM), leading the Institute of Biological and Medical Imaging at the Helmholtz Centre Munich. His research focuses on developing novel optical and optoacoustic imaging techniques for early disease detection, diagnostics, and theranostics. He holds a PhD in Bioengineering from the University of Pennsylvania and previously served as an Assistant Professor at Harvard University and Massachusetts General Hospital. Affiliations: TUM School of Medicine and Health, Helmholtz Munich, Institute of Biological and Medical Imaging. Key Research Themes: Non-invasive imaging methods, molecular imaging, optoacoustic technology, and clinical translation. His work bridges theoretical developments with clinical applications, including advancements in glucose monitoring, cancer imaging, and drug delivery systems. Notable awards include the Leibniz Prize (2013) and the World Molecular Imaging Society Gold Medal (2015). Labs/Teams: Imaging to Sensing I2S, Optoacoustic Mesoscopy, Fluorescence Imaging, and AI in Optoacoustics. Grants/Projects: Involvement in Horizon Europe initiatives and collaborations with TranslaTUM and Helmholtz Munich. Prof. Ntziachristos actively contributes to education via courses like 'Biological Imaging' and 'Introduction to Bioengineering', fostering the next generation of imaging scientists.

• Cancer Targeting
• Drug Design
• Drug Delivery
• +۴ مورد دیگر

About Dr. Pegah Varamini Dr. Pegah Varamini is a Senior Lecturer in Pharmacy and Pharmacology at the Sydney Pharmacy School, University of Sydney, and a Casual Lecturer in Music Education at the Sydney Conservatorium of Music. She leads the Breast Cancer Targeting & Drug Delivery (BCTDD) Group, focusing on innovative drug delivery systems for Triple Negative Breast Cancer (TNBC). Her research integrates nanotechnology, targeted therapy, and translational medicine, supported by prestigious grants including the NBCF Fellowship (2016). Research & Education PharmD (Shiraz University of Medical Sciences) PhD in Pharmaceutical Sciences (University of Queensland) Second PhD in Music Education (University of Sydney Conservatorium of Music) Key Research Interests Her work centers on: Peptide-based targeting strategies using 'Trojan Horse' approaches for TNBC Development of nanomedicine for bone metastasis prevention Clinically relevant preclinical models for personalized breast cancer treatment Collaborations with international institutions (e.g., Harvard Medical School, University of Nantes) Teaching & Supervision Dr. Varamini coordinates Drug Design and Development (PCOL3012/3912) and supervises a multidisciplinary team of HDR students and postdoctoral researchers. Notable current students include PhD candidate Hany Ghaly and MPhil candidates Huimin Shao and Farhana Mollah. Awards & Recognition 2021 Equity Prize 2016 Top 25 Young Researchers of Australia and New Zealand 2018 Fresh Scientist of the Year Recipient of multiple grants totaling over AUD 2M Leadership & Outreach She co-chairs the Nanopharma cluster at Sydney Nano Institute and advises the WHO Global Breast Cancer Initiative. Her work has been featured in media outlets such as SBS Farsi News and NBCF publications.

Yildiz Bayazitogluمشاهده پروفایل

استاد

• Thermal Sciences
• Heat Transfer
• Nanotechnology
• +۴ مورد دیگر

Dr. Yildiz Bayazitoglu is the Harry S. Cameron Professor of Mechanical Engineering and Professor of Materials Science and NanoEngineering at Rice University since 1996. She joined Rice in 1977 and has held prior roles as an assistant professor at Middle East Technical University (1973–74) and a visiting assistant professor at the University of Houston (1975–76). Her education includes a B.S. from Middle East Technical University (1967), and M.S. and Ph.D. from the University of Michigan (1969 and 1974). Her research focuses on convective heat transfer with phase change , micro/nano-scale heat transfer , and radiation heat transfer . Key areas include thermal modeling of biomedical systems, containerless materials processing, and fuel cell design. She has pioneered work on nanofluids, interfacial thermal resistance, and radiation shielding for aerospace applications. Dr. Bayazitoglu has published over 200 technical papers and holds patents in thermal engineering. She authored two heat transfer textbooks and serves as Editor-in-Chief of the International Journal of Thermal Sciences . Her honors include ASME’s Heat Transfer Memorial Award, AAAS and AIAA Fellowships, and membership in the Turkish Academy of Sciences. Education: B.S., Middle East Technical University (1967) M.S., University of Michigan (1969) Ph.D., University of Michigan (1974) Leadership Roles: Former Vice-President of the International Center for Heat and Mass Transfer (2019–2021) Member of Turkish Academy of Sciences Energy Sources Committee (2017–2018) Her work bridges thermal engineering with biomedical, aerospace, and materials science applications, emphasizing practical solutions to complex thermal challenges.

• Biomaterials
• Tissue Engineering
• Regenerative Medicine
• +۱۲ مورد دیگر

Professor Hala Zreiqat AM is a leading biomedical engineer at The University of Sydney , serving as the Director of the ARC Training Centre for Innovative BioEngineering . A Fellow of all major Australian academies (AAS, ATSE, FAHMS, FRSN), she develops 3D printed bioceramics for bone regeneration while championing diversity through initiatives like the IDEAL Society and BIOTech Futures mentorship program. Her work bridges academia, clinical practice, and industry in musculoskeletal research . Research Focus: Her lab creates synthetic bone scaffolds that mimic natural bone architecture, strength, and porosity, enabling non-rejected bone regeneration via patient-matched implants. Key applications include orthopaedic, dental, and maxillofacial repair , with over $18M in competitive funding and multiple patents. Current projects explore AI-driven scaffold performance prediction and anti-senescence strategies for aging-related bone loss. Scientific Trends: Recent publications highlight 3D printed nanovoxelated ceramics , antisenescence biomaterials , and multifunctional theranostic platforms . Her team integrates machine learning for scaffold design, atom probe tomography for interface analysis, and two-photon imaging for cellular monitoring in 3D environments. 2021-2022 Fulbright Senior Scholar 2018 NSW Premier's Woman of the Year 2019 Eureka Prize for Innovative Use of Technology Fellow of Australian Academy of Science (2021) Over $18M in research funding Teaching & Leadership: She designed core courses like Tissue Engineering and Nanomaterials in Medicine , mentoring 158 students in 2020 alone. As Chair of CAAR (2020-2023), she strengthens Australia-Arab collaborations. Her lab trains early-career researchers , with alumni now in academia and industry.

Ashis K. Patraمشاهده پروفایل

استاد

• Inorganic Chemistry
• Bioinorganic Chemistry
• Therapeutic Applications of Metal Complexes
• +۳ مورد دیگر

Ashis K. Patra is a full-time Professor in the Department of Chemistry at the Indian Institute of Technology Kanpur (IIT Kanpur). After obtaining his Ph.D. from the Indian Institute of Science (IISc) Bangalore in 2008, he carried out post-doctoral research at Harvard University and the University of Georgia before joining IIT Kanpur in 2012. Education & Academic Training Ph.D. (2008), Indian Institute of Science (IISc), Bangalore M.Sc. (2002), The University of Burdwan Research Interests Professor Patra leads an interdisciplinary program that sits at the interface of inorganic chemistry, chemical biology, and medicinal chemistry. His work is organized into three principal thrusts: Therapeutic Applications of Metal Complexes: Design and mechanistic evaluation of cytotoxic transition-metal complexes that target nucleic acids and proteins, aiming to overcome multidrug resistance in cancer. Nitric Oxide Delivery from Transition Metal Nitrosyls: Development of photo- and redox-triggered metal nitrosyl complexes for controlled NO release to biological targets such as hemoglobin, myoglobin, and glutathione. Luminescent Lanthanide Complexes: Synthesis and photophysical characterization of Eu(III) and Tb(III) complexes that serve as luminescent probes and theranostic agents. Research Output & Impact His group has published extensively in leading journals including Dalton Transactions , Inorganic Chemistry , Chemical Science , and Journal of Inorganic Biochemistry . The collective work demonstrates a clear trajectory from fundamental coordination chemistry to translational applications in drug delivery and bioimaging, with recurring themes of redox control, light activation, and biological targeting. Scientific Awards & Fellowships CSIR Junior & Senior Research Fellowships (2001, 2003) West Bengal SLET Qualification (2001) International Travel Grants from CSIR & INSA (2006) DST Fast-Track Fellowship for Young Scientists (2013) Erasmus Mundus NAMASTE Scholarship for Academic Staff (2014) JSPS Invitation Fellowship (2016) Teaching & Mentoring Professor Patra teaches core and advanced courses in inorganic chemistry, including Inorganic Chemistry Laboratory, Bioinorganic Chemistry, and Frontiers in Inorganic Chemistry. He actively mentors Ph.D. and master’s students (full list available on his lab website ) and has established the Laboratory of Inorganic Chemical Biology in the Old Core Lab complex at IIT Kanpur.

• Optics in Medicine
• Cancer Imaging
• Photodynamic Therapy
• +۵ مورد دیگر

Brian W. Pogue, Ph.D., is the Robert A. Pritzker Chair in Biomedical Engineering at Dartmouth College's Thayer School of Engineering, with a joint appointment as an Honorary Fellow in Medical Physics at the University of Wisconsin-Madison. His academic background includes a Ph.D. in Medical/Nuclear Physics from McMaster University and a Research Fellowship at Harvard Medical School's Wellman Center for Photomedicine. He has led significant administrative roles, including Dean of Graduate Studies at Dartmouth (2008–2012) and Chair of Medical Physics at Wisconsin (2022–2025). Research Focus : Dr. Pogue pioneers Optics in Medicine , specializing in cancer imaging, photodynamic therapy, and surgical guidance. His work integrates fluorescence imaging, radiation therapy monitoring, and molecular diagnostics to improve cancer treatment precision. Key innovations include Cherenkov imaging for radiotherapy dosimetry and hypoxia-sensitive probes for tumor resection. Publication Trends : Recent articles (2023–2025) emphasize real-time surgical guidance, hypoxia quantification, and multimodal imaging systems. Dominant themes include fluorescence tomography, radiation dosimetry, and low-cost diagnostic devices, reflecting a translational focus from preclinical validation to clinical applications. Awards & Honors : Fellow, Optica (formerly OSA) Fellow, American Institute for Medical and Biological Engineering (AIMBE) Fellow, American Association of Physicists in Medicine (AAPM) Fellow, SPIE (International Society for Optics and Photonics) Funding & Innovation : Continuously funded by the NIH since 2001 ($52M+ total), Dr. Pogue founded three startups: DoseOptics LLC (radiotherapy dose imaging) and Hypoxia Surgical LLC (tissue hypoxia cameras), bridging academic research to clinical tools.

• Catalysis
• Nanotechnology
• Environmental Chemistry
• +۳ مورد دیگر

Dr. Suresh Bhargava is a Distinguished Professor and Director of AcSIR at RMIT University's Research & Innovation department. He has led interdisciplinary research in materials science, catalysis, and environmental engineering for over three decades, with a focus on strengthening Indo-Australian scientific collaboration. His work bridges academia and industry, addressing challenges in pollution control, nanotechnology, and cancer treatment. Research & Leadership: Established RMIT's Centre for Advanced Materials and Industrial Chemistry (CAMIC), pioneering translational research with industry applications. Supervised 70+ PhD students (100% employment rate), many now leading roles at global institutions. Holds distinguished professorships across six countries and advises governments and Fortune 500 firms on environmental and industrial issues. Awards & Recognition: Recipient of Australia's Member of the Order of Australia (2022), India's P.C. Ray Chair (2014), and the Khwarizmi International Award (2016). His work on mercury pollution control and gold-based anticancer drugs has garnered global acclaim, with over 800 publications (26,000+ citations, h-index 86). Key Contributions: Architect of the Australia-India Strategic Research Fund and the RMIT-AcSIR Joint Research Program. Innovated eco-friendly graphene production from eucalyptus bark and patented anti-cancer gold compounds. Advises on sustainable mineral processing, hydrogen energy, and CO₂ valorization. Industry Engagement: Consulted for Rio Tinto, BHP Billiton, and CSIRO on resource efficiency, pollution mitigation, and nanotechnology applications. His research has created jobs and driven innovation in Australia and Asia-Pacific.

• Cancer Biology
• Gene Regulation
• Breast Cancer
• +۶ مورد دیگر

Dr. Thomas A. Hughes is an Associate Professor of Cancer Biology at the University of Leeds and Professor of Biosciences at York St John University. As a Group Leader at the Leeds Institute of Medical Research, he focuses on gene regulation, tumour microenvironment, and nanomedicine approaches to improve cancer outcomes. Specializes in breast cancer, colorectal cancer, and rare diseases Develops therapeutic strategies using microRNAs and biomarkers Collaborates with clinicians, engineers, and chemists for translational research His research integrates molecular pathology with clinical data through partnerships with Leeds NHS Trusts, aiming to identify novel biomarkers and targets for therapy. Recent work emphasizes cholesterol metabolism, oxysterol signaling, and nanomedicine-based drug delivery systems. Key contributions include: Over 80 peer-reviewed publications in cancer biology and molecular therapeutics Leadership in MSc programs in Molecular Medicine and Cancer Biology and Therapy Extensive experience in grant review, editorial work, and doctoral supervision Scientific awards include Fellowship of the Higher Education Academy. His lab has mentored 26 doctoral students and numerous alumni in academia, clinical practice, and industry.

Pengyu Chenمشاهده پروفایل

دانشیار

• Nanoplasmonic Biosensors
• Single-cell Analysis
• Precision Medicine
• +۳ مورد دیگر

Pengyu Chen is Francis Family Associate Professor and Ginn Faculty Achievement Fellow in Materials Engineering at Auburn University. His NIH-funded research develops nanoplasmonic biosensors for rapid disease diagnosis and immune monitoring, with applications in precision medicine and cancer immunotherapy. Research focuses on: Rapid diagnostic technologies for COVID-19 and other diseases Single-cell analysis platforms Nanoparticle-based cancer therapies Food/environmental safety monitoring Recent publications demonstrate innovations in nanoplasmonic sensing, targeted drug delivery, 3D-printed implants, and tumor microenvironment analysis. His work integrates nanotechnology, immunology, and microfluidics for biomedical applications.

• Membrane Biophysics
• Bioengineering
• Nanotechnology
• +۷ مورد دیگر

Henry Liang, Ph.D., is a Professor in the Department of Cell Physiology and Molecular Biophysics at Texas Tech University Health Sciences Center (TTUHSC), with adjunct appointments in Chemical Engineering and Chemistry at Texas Tech University. His lab focuses on bridging biology with synthetic systems through membrane biophysics and bioengineering. Research Interests: Dr. Liang's work spans membrane protein reconstitution, nanodisc technology, antimicrobial nanoparticles, blood-brain barrier targeting, and immunotherapy platforms. Key areas include: Design of synthetic proteomembranes for protein function studies Development of environmentally responsive nanoantibiotics Nanoparticle-based theranostic systems for cancer Light-driven energy transduction in biohybrid materials Publication Trends: His 15 most recent articles (2011-2023) demonstrate consistent focus on nanotechnology solutions for biomedical challenges, with evolving emphasis on antimicrobial nanostructures (35%), membrane protein platforms (30%), cancer nanomedicine (20%), and sustainable nanomaterials (15%). Methodological strengths include polymer synthesis, X-ray scattering, and biomimetic system design. Training: The Liang Lab actively recruits graduate students and postdoctoral researchers for projects in membrane biophysics and bioengineering. Current research infrastructure includes capabilities for synchrotron small-angle X-ray scattering, molecular dynamics simulations, and nanomaterial characterization.

• Molecular Imaging
• Biomedical Imaging
• Optical Coherence Tomography
• +۳ مورد دیگر

Adam de la Zerda is an Associate Professor at Stanford University's Department of Structural Biology (School of Medicine) and Electrical Engineering (by courtesy). He develops advanced optical molecular imaging technologies combining nanoparticle contrast agents and adaptive OCT systems for cancer and ophthalmic disease research. Technion-Israel Institute of Technology (BSc, 2005) Stanford University (PhD, 2011) UC Berkeley (Postdoctoral Fellowship) Research Themes : Virtual biopsy using machine learning-enhanced OCT Gold nanorod-based molecular contrast agents Speckle noise reduction for cellular resolution Needle beam optical coherence tomography angiography His 15 most recent publications demonstrate technical innovations in: Metasurface optics for extended depth-of-field Spectral deconvolution of multiple contrast agents Speckle modulation for improved diagnostic clarity Noninvasive lymphatic system mapping Scientific Honors : Pew-Stewart Scholar for Cancer Research AFOSR Young Investigator NIH Early Independence Award Forbes 30 Under 30 (x2) Chan Zuckerberg BioHub Investigator His lab team has developed clinical prototypes including OcuBell Inc. 's ophthalmic imaging systems and Visby Medical 's diagnostic platforms. Current research spans from in vivo glycoprotein imaging to de novo biosensor development for real-time disease monitoring in awake animal models.

Paras N. Prasadمشاهده پروفایل

استاد

• Photonics
• Nanophotonics
• Biophotonics
• +۴ مورد دیگر

Paras N. Prasad is a SUNY Distinguished Professor with joint appointments in Physics, Chemistry, Medicine, and Electrical Engineering at the University at Buffalo. He serves as Executive Director of the Institute for Lasers, Photonics and Biophotonics (ILPB), which he founded in 1999. Dr. Prasad holds the Samuel P. Capen Chair of Chemistry and has pioneered interdisciplinary research at the interface of photonics, nanotechnology, and biomedicine. Education: BSc, Bihar University, India (1964) MSc, Bihar University, India (1966) PhD, University of Pennsylvania (1971) Postdoctoral Fellow, University of Michigan (1971-74) Research Focus: Dr. Prasad's multidisciplinary research spans photonics, nanophotonics, and biophotonics, with emphasis on nonlinear optical processes in nanostructured materials. His work develops photonic technologies for information processing, medical imaging, and cancer therapy through nanoparticle-based drug delivery systems and diagnostic platforms. The ILPB laboratory features state-of-the-art instrumentation for advanced optical research. Publication Trends: Recent articles demonstrate strong focus on nanomedicine applications, particularly cancer theranostics using functional nanoparticles. Key themes include drug delivery systems, chiral photonic materials, bioimaging technologies, and nanoparticle synthesis techniques. The research consistently bridges fundamental materials science with translational medical applications. Honors and Awards: SPIE Gold Medal (2016) IEEE Photonics Society William Streifer Award (2021) American Chemical Society Peter Debye Award (2018) OSA Michael Feld Biophotonics Award (2017) IEEE Pioneer Award in Nanotechnology (2017) Fellow of National Academy of Inventors (2016) Guggenheim Fellowship (1997) Leadership: As ILPB Executive Director, Dr. Prasad leads multidisciplinary teams developing photonic technologies with applications in healthcare, energy, and communications. His research has generated nine spin-off companies, including Nanobiotix currently in advanced cancer therapy trials.

John F Valliantمشاهده پروفایل

استاد

• Radiopharmaceutical Chemistry
• Nuclear Medicine
• Molecular Imaging
• +۵ مورد دیگر

John F Valliant is a Professor in the Department of Chemistry and Chemical Biology at McMaster University. His research focuses on radiopharmaceutical chemistry, molecular imaging, and targeted therapies, particularly in cancer diagnostics and therapeutics. He co-founded Fusion Pharmaceuticals, a company acquired by AstraZeneca for $2.4 billion (US), which specializes in targeted alpha therapy for cancer treatment. His work includes developing radiolabeled imaging agents for prostate cancer (e.g., [18F]DCFPyL), targeted alpha therapies (e.g., FPI-1434), and bioorthogonal chemistry strategies for pretargeted imaging. Valliant has contributed to advancements in photoacoustic imaging, SPECT/PET modalities, and theranostic agents for conditions like bacterial infections and bone diseases. Key projects include the Phase II clinical trial using 18F-DCFPyL PET-MRI for oligometastatic prostate cancer and studies on individualized dosimetry in Lu-177 therapies. He has pioneered platforms for radiolabeled antibody-recruiting molecules and fluorous-phase chemistry for high-specific-activity probes. Valliant’s research bridges disciplines, integrating chemistry, biology, and clinical applications to address unmet medical needs in oncology and diagnostic imaging.

Ravi Shuklaمشاهده پروفایل

استاد

• Nanobiotechnology
• Bioscience
• Medical Biotechnology
• +۶ مورد دیگر

Professor Ravi Shukla is a faculty member at RMIT University's School of Science, holding the title of Professor and Deputy Head of Department (Research). He specializes in Nanobiotechnology, with research spanning biomaterials, drug delivery systems, and medical diagnostics. His work integrates biosciences, materials science, and food technology to advance understanding of nanomaterial-biomolecular interactions. Academic History: Professor Shukla has held roles at RMIT since 2011, progressing from Research Fellow to his current professorship. He also serves as an Adjunct Professor at the University of Missouri and Theme Leader for Nanobiotechnology at RMIT’s Center for Advanced Materials and Industrial Chemistry. His teaching focuses on fostering student belonging and innovation in biotechnology education, including coordinating RMIT’s undergraduate Biotechnology program. Research Interests: His lab explores hybrid biomaterial synthesis, nano-enabled proteomics, and non-viral gene therapy using MOFs. Recent work emphasizes applications in diabetes biosensing, CRISPR/Cas9 delivery, and antimicrobial resistance mitigation through nanostrategies. Over 130+ publications and substantial research funding highlight his interdisciplinary impact. Professional Engagement: Editor roles in Frontiers in Bioengineering and Biotechnology , Co-Editor-in-Chief of Current Research in Nutrition and Food Science , and advisor to the Australasian Association of Ayurveda underscore his leadership. He actively mentors students in projects like nano-antimicrobial wound healing and aptamer-based hepatitis A detection. Key Achievements: Pioneered nucleic acid-encapsulated MOFs for cancer therapy and developed paper-based biosensors for rapid diagnostics. His work aligns with UN Sustainable Development Goals 2 (Zero Hunger) and 3 (Good Health).